» Articles » PMID: 30898038

Elevated Pulmonary Tuberculosis Biomarker MiR-423-5p Plays Critical Role in the Occurrence of Active TB by Inhibiting Autophagosome-lysosome Fusion

Overview
Date 2019 Mar 23
PMID 30898038
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Rapid diagnosis of pulmonary tuberculosis is an effective measure to prevent the spread of tuberculosis. However, the grim fact is that the new, rapid, and safe methods for clinical diagnosis are lacking. Moreover, although auto-lysosome is critical in clearing Mycobacterium tuberculosis, the pathological significance of microRNAs, as biomarkers of tuberculosis, in autophagosome maturation is unclear. Here, these microRNAs were investigated by Solexa sequencing and qPCR validation, and a potential diagnostic model was established by logistic regression. Besides that, the mechanism of one of the microRNAs involved in the occurrence of tuberculosis was studied. The results showed that the expression of miR-423-5p, miR-17-5p, and miR-20b-5p were significantly increased in the serum of patients with tuberculosis. The combination of these three microRNAs established a model to diagnose tuberculosis with an accuracy of 78.18%, and an area under the curve value of 0.908. Bioinformatics analysis unveiled miR-423-5p as the most likely candidate in regulating autophagosome maturation. The up-regulation of miR-423-5p could inhibit autophagosome maturation through suppressing autophagosome-lysosome fusion in macrophages. Further investigations showed that VPS33A was the direct target of miR-423-5p, and the two CUGCCCCUC domains in VPS33A 3'-UTR were the direct regulatory sites for miR-423-5p. In addition, an inverse correlation between VPS33A and miR-423-5p was found in peripheral blood mononuclear cells of patients with tuberculosis. Since the inhibition of autolysosome formation plays a critical role in tuberculosis occurrence, our findings suggests that miR-423-5p could suppress autophagosome-lysosome fusion by post-transcriptional regulation of VPS33A, which might be important for the occurrence of active tuberculosis.

Citing Articles

Circulating MicroRNAs as Biomarkers for the Early Diagnosis of Lung Cancer and Its Differentiation from Tuberculosis.

Ashirbekov Y, Khamitova N, Satken K, Abaildayev A, Pinskiy I, Yeleussizov A Diagnostics (Basel). 2024; 14(23).

PMID: 39682592 PMC: 11640063. DOI: 10.3390/diagnostics14232684.


Unlocking the potential of miRNAs in detecting pulmonary tuberculosis: prospects and pitfalls.

Arya R, Kumar S, Vinetz J, Kim J, Chaurasia R Expert Rev Mol Med. 2024; 26:e32.

PMID: 39639643 PMC: 11629464. DOI: 10.1017/erm.2024.29.


MicroRNAs regulating autophagy: opportunities in treating neurodegenerative diseases.

Mohseni M, Behzad G, Farhadi A, Behroozi J, Mohseni H, Valipour B Front Neurosci. 2024; 18:1397106.

PMID: 39582602 PMC: 11582054. DOI: 10.3389/fnins.2024.1397106.


Single molecule measurements of microRNAs in the serum of patients with pulmonary tuberculosis.

Wu Z, Tan Q, Jia X, Wu H, Liang J, Wen W Front Immunol. 2024; 15:1418085.

PMID: 39286248 PMC: 11402676. DOI: 10.3389/fimmu.2024.1418085.


The role of exosomal miRNAs in host pathogen cross-talk as diagnostic and therapeutic biomarkers.

Mukhtar F, Guarnieri A, Brancazio N, Falcone M, Di Naro M, Azeem M Front Microbiol. 2024; 15:1441781.

PMID: 39176271 PMC: 11340542. DOI: 10.3389/fmicb.2024.1441781.


References
1.
Giosue S, Casarini M, Ameglio F, Zangrilli P, Palla M, Altieri A . Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis. Eur Cytokine Netw. 2000; 11(1):99-104. View

2.
Lewis B, Shih I, Jones-Rhoades M, Bartel D, Burge C . Prediction of mammalian microRNA targets. Cell. 2003; 115(7):787-98. DOI: 10.1016/s0092-8674(03)01018-3. View

3.
Enright A, John B, Gaul U, Tuschl T, Sander C, Marks D . MicroRNA targets in Drosophila. Genome Biol. 2004; 5(1):R1. PMC: 395733. DOI: 10.1186/gb-2003-5-1-r1. View

4.
Gutierrez M, Master S, Singh S, Taylor G, Colombo M, Deretic V . Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 2004; 119(6):753-66. DOI: 10.1016/j.cell.2004.11.038. View

5.
Bardag-Gorce F, Francis T, Nan L, Li J, Lue Y, French B . Modifications in P62 occur due to proteasome inhibition in alcoholic liver disease. Life Sci. 2005; 77(20):2594-602. DOI: 10.1016/j.lfs.2005.04.020. View